ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 241 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $48,515,000 | +24.1% | 522,000 | -20.5% | 0.24% | +33.0% |
| Q3 2021 | $39,097,000 | -32.6% | 656,548 | -22.8% | 0.18% | -23.2% |
| Q2 2021 | $57,970,000 | -1.7% | 850,000 | 0.0% | 0.24% | -19.1% |
| Q1 2021 | $58,982,000 | +2.4% | 850,000 | +13.3% | 0.29% | -15.6% |
| Q4 2020 | $57,623,000 | +22.3% | 750,000 | +19.1% | 0.35% | +6.4% |
| Q3 2020 | $47,109,000 | -16.8% | 629,886 | -30.0% | 0.33% | -28.0% |
| Q2 2020 | $56,655,000 | – | 900,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |